38 articles in this topic
A major NIH-backed study finds that daily low-dose aspirin does not extend healthy lifespan in older people, challenging a long-held preventive health belief.
Johns Hopkins research finds combining cannabis edibles with alcohol impairs driving far beyond either substance alone, evading standard sobriety tests.
A landmark 8,500-patient trial challenges 40 years of cardiology practice, finding beta blockers unnecessary after uncomplicated heart attacks.
A newly discovered protein called HELZ2 controls how much harmful cholesterol the liver releases, opening a fresh path to heart disease treatment.
A newly funded NIH study introduces improved predictive measures for a chronic heart condition, potentially reshaping clinical risk assessment.
UC San Diego scientists developed an injectable hydrogel that travels the bloodstream to reduce inflammation and regenerate damaged heart tissue.
Major cardiology groups recommend cholesterol screening in childhood for some, plus new genetic risk factors like lipoprotein(a) testing.
Analysis of 123,940 patients reveals most reported statin side effects occur equally in placebo groups, challenging widespread medication fears.
New study reveals ischemic heart disease rising 3.79% annually across Southeast Asia, East Asia and Oceania, driven by regional risk factors.
New study shows replacing just 30 minutes of sitting with light activity cuts cardiovascular risk by over half after cardiac events.
PREVENT tool combined with calcium scoring improves heart attack prediction in 7,000-person study, enabling better preventive care decisions.
Swedish researchers discover genetic mutations that dramatically increase venous blood clot risk, offering new insights for prevention.
